m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00032)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
hsa-miR-183-3p
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Heterogeneous nuclear ribonucleoproteins C1/C2 (HNRNPC) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | rs7495 in 3'UTR of hnRNPC was associated with pancreatic ductal adenocarcinoma susceptibility in a Chinese population. The rs7495, in the hnRNPC 3'UTR, might disrupt a binding site for hsa-miR-183-3p, thus increasing the expression of hnRNPC and promoting the proliferation of PDAC cells. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Pancreatic ductal adenocarcinoma | ICD-11: 2C10.0 | ||
In-vitro Model | BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 |
CFPAC-1 | Cystic fibrosis | Homo sapiens | CVCL_1119 | |
Pancreatic cancer [ICD-11: 2C10]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | rs7495 in 3'UTR of hnRNPC was associated with pancreatic ductal adenocarcinoma susceptibility in a Chinese population. The rs7495, in the hnRNPC 3'UTR, might disrupt a binding site for hsa-miR-183-3p, thus increasing the expression of hnRNPC and promoting the proliferation of PDAC cells. | |||
Responsed Disease | Pancreatic ductal adenocarcinoma [ICD-11: 2C10.0] | |||
Target Regulator | Heterogeneous nuclear ribonucleoproteins C1/C2 (HNRNPC) | READER | ||
Target Regulation | Down regulation | |||
In-vitro Model | BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 |
CFPAC-1 | Cystic fibrosis | Homo sapiens | CVCL_1119 | |